GIBSON NEIL 4
4 · OSI PHARMACEUTICALS INC · Filed Sep 14, 2004
Insider Transaction Report
Form 4
GIBSON NEIL
VP & Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2004-09-13$30.74/sh+2,000$61,480→ 3,590 total - Sale
Common Stock
2004-09-13$63.03/sh−200$12,606→ 1,915 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-09-13−2,000→ 17,200 totalExercise: $30.74From: 2004-06-25Exp: 2013-06-24→ Common Stock (2,000 underlying) - Sale
Common Stock
2004-09-13$63.00/sh−1,175$74,025→ 2,415 total - Sale
Common Stock
2004-09-13$63.02/sh−300$18,906→ 2,115 total - Sale
Common Stock
2004-09-13$63.07/sh−125$7,884→ 1,590 total
Footnotes (3)
- [F1]One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months.
- [F2]The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3.
- [F3]Includes only options with the same termination date.